Bioavailability of antiglaucoma drugs;Biodisponibilite des medicaments hypotonisants

Journal Francais d'Ophtalmologie

Volumn 23, Issue 5, 2000, Pages 518-522

  Demailly, Ph ^a  

^a NONE   (France)

Author keywords

Beta blockers; Bioavailability; Carbon anhydrase inhibitors; Glaucoma; Mitotics; Prostaglandins; Sympatomimetics

Indexed keywords

ACETAZOLAMIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; APRACLONIDINE; BEFUNOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; DIPIVEFRINE; DORZOLAMIDE; EYE DROPS; LEVOBUNOLOL; METIPRANOLOL; PILOCARPINE; TIMOLOL; MIOTIC AGENT;

ARTICLE; CORNEA PERMEABILITY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG PENETRATION; GLAUCOMA; HUMAN; LACRIMAL FLUID; BIOAVAILABILITY; CORNEA; METABOLISM; REVIEW;

BIOLOGICAL AVAILABILITY; CORNEA; GLAUCOMA; HUMANS; MIOTICS; OPHTHALMIC SOLUTIONS;

EID: 0034087819     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Anderson JA. Systemic absorption of topical ocularly applied Epinephrine and Dipivefrin. Arch ophtalmol, 1980;98: 350-3.
2. Cantor LB, Burke J. Drug évaluation: Pulmonary-allergy, dermatological, gastrointestinal and arthritis. Brimonidine. Exp Opin Invest Drugs, 1997;6(8):1063-83.
3. Demailly Ph et coll. Traitement actuel du glaucome primitif à angle ouvert. Rapport de la Société Française d'ophtalmologie 1989 - Masson édit.
4. Levobunolol study group. Levobunclol: a four years study of efficacy and safety in glaucoma treatment. Ophtalmology, 1989;96:642-5.
5. Maren TH. Mise au point sur les inhibiteurs locaux de l'anhydrase carbonique. Journal du glaucome : 4 : 49 62, Raven Press, New York ; 1995 Raven Press Ltd.
6. Tae Woo Kim, Dong Myung Kim. Effects of 0.5% apraclonidine on optic nerve head and peripapillary retinal blood flow. Br J ophtalmol, 1997;81:1070-2.
7. VIDAL, 1998.